AYTU BIOPHARMA, INC Gain (Loss) on Termination of Lease
AYTU BIOPHARMA, INC (AYTU) reported Gain (Loss) on Termination of Lease of $343.00 thousand for the 9-month period ending 2021-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2022-05-16
- AYTU BIOPHARMA, INC gain (loss) on termination of lease for the quarter ending 2020-09-30 was $343.00K.
- AYTU BIOPHARMA, INC gain (loss) on termination of lease for the quarter ending 2019-09-30 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 3 month as first filed | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 6 month as first filed | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 9 month as first filed |
|---|---|---|---|---|---|---|
| 2021-03-31 | $343.00K 10-Q · filed 2022-05-16 | $343.19K 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $343.00K 10-Q · filed 2022-02-14 | $343.19K 10-Q · filed 2021-02-11 | ||||
| 2020-09-30 | $343.00K 10-Q · filed 2021-11-15 | $343.19K 10-Q · filed 2020-11-12 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |